首页 › 基金 › Rosalind Advisors, Inc. › ABVX
Rosalind Advisors, Inc. 对 ABVX 的持仓历史
ABIVAX SA · 医疗保健
Rosalind Advisors, Inc. 在 Q3 2026 的 13F 申报中披露持有 ABVX(ABIVAX SA)20,869 股,市值约 US$2.1M,约占其申报组合的 0.84%,在其申报持仓中市值排名第 21 位。 Rosalind Advisors, Inc. 最近 11 个申报季度中有 5 个季度披露了 ABVX 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Rosalind Advisors, Inc. 对 ABVX 的持仓演变
Rosalind Advisors, Inc. 于 Q1 2024 首次披露 ABVX 持仓:378,416 股(约 US$5.4M)。 在 5 次申报中,Rosalind Advisors, Inc. 0 次增持、1 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 20,869 股、市值约 US$2.1M。 持仓曾出现大幅变动:Q3 2024 减持约 63% (随后一个季度股价下跌 36%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 378.42K | $5.41M | 新进 |
| Q2 2024 | 378.42K | $5.00M | 持有 |
| Q3 2024 | 139.98K | $1.61M | 减持 |
| Q2 2026 | 20.87K | $2.78M | 新进 |
| Q3 2026 | 20.87K | $2.07M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ABVX 与 13F 数据
ABVX(ABIVAX SA)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 ABVX,申报仓位最大的包括:Helikon Investments Ltd (US$418.2M), TCG Crossover Management, LLC (US$362.7M), Darwin Global Management, Ltd. (US$348.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ABVX 的基金
- Helikon Investments Ltd 4.22M 股 · $418.15M · Q3 2026
- TCG Crossover Management, LLC 3.66M 股 · $362.71M · Q3 2026
- Darwin Global Management, Ltd. 3.62M 股 · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M 股 · $313.09M · Q2 2026
- Caligan Partners LP 1.56M 股 · $207.61M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.65M 股 · $163.56M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M 股 · $150.92M · Q2 2026
- Octagon Capital Advisors LP 993.00K 股 · $132.33M · Q2 2026
- Eversept Partners, LP 1.10M 股 · $108.99M · Q3 2026
- Cormorant Asset Management, LP 675.00K 股 · $89.95M · Q2 2026
- Logos Global Management LP 870.00K 股 · $86.15M · Q3 2026
- Boxer Capital Management, LLC 605.00K 股 · $80.62M · Q2 2026
更多关于 Rosalind Advisors, Inc.
常见问题
How long has Rosalind Advisors, Inc. held ABVX?
Rosalind Advisors, Inc. has disclosed ABVX holdings in 5 of the last 11 reported quarters, going back to Q1 2024.
What is Rosalind Advisors, Inc.'s current position in ABVX?
As of Q3 2026, Rosalind Advisors, Inc. holds 20.87K shares of ABVX (ABIVAX SA), valued at $2.07M, representing 0.84% of its reported portfolio and ranking #21.
Has Rosalind Advisors, Inc. been buying or selling ABVX?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. held unchanged its position in ABVX.
Which other funds hold ABVX?
Other major institutional holders of ABVX include Helikon Investments Ltd, TCG Crossover Management, LLC, Darwin Global Management, Ltd., among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.